Merck
4 stories
-
healthmRNA Vaccine Slashes Melanoma Recurrence Risk in Landmark Trial
A new mRNA cancer therapy from Merck and Moderna cuts melanoma recurrence or death risk by 49% over five years, offering new hope for late-stage patients.
-
sportsAlbert Pujols Joins Heart Health Campaign Honoring Late Teammate Darryl Kile
MLB legend Albert Pujols partners with Merck and Adam Wainwright to raise awareness about heart disease and high cholesterol.
-
healthHPV Vaccine: Your Shield Against Common Cancers
Understand why the HPV vaccine is crucial for preventing various cancers, including cervical, head, and neck cancers. Learn who should get vaccinated.
-
healthLynch Syndrome: What Every Woman Should Know About Genetic Cancer Risk
Understanding Lynch syndrome, a genetic condition increasing cancer risk, and what women need to know about testing and management.